Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Recombinant Bacteria. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117305200A reveals efficient recombinant bacteria route. Offers scalable production and cost advantages for global pharmaceutical supply chains.
CN117305198A reveals high-efficiency recombinant bacterium method for L-Dopa. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104152505B enables high-yield 4HIL production via recombinant strains. Offers cost reduction and supply chain reliability for diabetes drug intermediates.